Manufacturers of needle-free IV connectors are working hard to create new solutions for their customers. NeutraClear needle-free connectors with an orange indicator are available from manufacturers such as Becton, Dickinson and Company to reduce unintentional luer removals. ICU Medical Inc. also has its own patented needle-free connector technology, in which the connectors are silicon sealed to limit contact between the connector's external and internal surfaces, reducing bacterial contamination. Many local players of needle-free IV connectors may be found in Asian nations such as India, China, and Indonesia. In China, for example, there are more than 30 native players.
Needle-free IV connectors are divide
d into basic and sophisticated categories based on the internal characteristics and functions of the pieces. Apart from the convenience of infusion for both care providers and patients, the use of needle-free IV connections reduces the risk of needle-stick accidents among health care personnel during surgeries, as well as the risk of bacterial and microbial contamination because they are disposable goods.
In hospitals and healthcare settings, improper syringe and needle use can lead to infections, diseases, and even death. The market for needle-free IV connections is predicted to expand due to an increase in the incidence of blood-borne infections such as hepatitis B and C and related mortality caused by inappropriate needle use over the forecast period. According to data published by the World Health Organization (WHO) in 2014, over 1.3 million deaths worldwide are reported each year as a result of improper use of syringes and needles, which can be avoided by using needle-free IV connectors. According to the same source, improper injections cause 5% of HIV cases, 40% of Hepatitis C cases, and 40% of Hepatitis B cases.
Furthermore, due to rising demand for needle-free IV connectors to minimise needle-stick injuries among healthcare professionals, the needle-free IV connector market is likely to develop significantly throughout the forecast period. According to a December 2013 estimate from the Centers for Disease Control and Prevention (CDC), roughly 385,000 needle stick injuries were reported among healthcare professionals in the United States.
Product recalls due to product failures, component inconsistency, and a lack of product handling knowledge are all projected to slow the global needle-free IV connections market growth throughout the forecast period. The U.S. Food and Drug Administration recalled Becton Dickinson & Company's CareFusion MaxPlus Clear Needleless Connector in May 2019. Because of the connector's loose fit with the luer, it was rejected by the FDA. The loose fitting is likely to increase the danger of blood loss and the production of an air embolism (air bubble) in the bloodstream, which could injure the patient unexpectedly, particularly in neonates.
The global needle-free IV connections market is predicted to be dominated by North America, followed by Europe. This is primarily due to North America's growing senior population and chronic diseases. According to the Centers for Disease Control and Prevention (CDC), in 2016, approximately half of all adults in the United States, or 117 million individuals, had one or more chronic health issues, and one out of every four persons had two or more chronic health conditions.
Government investments and financing to develop healthcare infrastructure, as well as public awareness about the use of needle-free IV connectors among people and healthcare practitioners, are driving the growth of the needle-free IV connectors market. The National Healthcare Safety Network (NHSN) and the Centers for Disease Control and Prevention (CDC) established guidelines for the prevention of central-line-associated bloodstream infections in 2013. In addition, the CDC used surveillance tools to identify and track device-associated infections in hospitals.
Comments
Post a Comment